Boehringer Ingelheim has agreed to pay $650 million to wrap up thousands of lawsuits claiming Pradaxa, an <a href="http://www.fiercepharma.com/tags/anticoagulant">anticoagulant</a>, caused serious–even fatal–bleeding in some patients. The deal comes just weeks after the FDA completed a safety review of the drug, concluding that it was as safe as the older drug it seeks to replace, warfarin.
written on 28.05.2014
Boehringer to pay $650M to wrap up thousands of Pradaxa lawsuits
